Latest News
-
FDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12
06/24/2019—The indication for a cystic fibrosis treatment, Symdeko (tezacaftor/ivacaftor) tablets, has been expanded to treat children ages 6 years and older with cystic fibrosis and certain genetic mutations, the U.S. Food and Drug Administration announced today. More
-
'Secret Shopper' Study Shows How Easily Teens Can Buy E-Cigs
06/24/2019—Despite federal and state age restrictions on the sale of tobacco and vaping products, a new "secret shopper" study found that IDs were checked only about half the time. More
-
Widely Prescribed Class of Meds Might Raise Dementia Risk
06/24/2019—Doctors often prescribe anticholinergic drugs for a variety of ills. But a new study suggests they may increase the risk of dementia in older patients. More
-
Just How Harmful Is TV for Your Health?
06/24/2019—A number of studies cite health risks due to the link between a sedentary lifestyle and the number of hours spent watching the tube. More
